Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Northwestern University
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
Lorenzo Gallon, Northwestern University Identifier:
First received: March 19, 2009
Last updated: May 13, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)